Kalafev 50 mg/ml, ενέσιμο διάλυμα για βοοειδή, άλογα και χοίρους
Kalafev 50 mg/ml, ενέσιμο διάλυμα για βοοειδή, άλογα και χοίρους
Authorised
- Flunixin meglumine
Product identification
Medicine name:
Kalafev 50 mg/ml, ενέσιμο διάλυμα για βοοειδή, άλογα και χοίρους
Active substance:
- Flunixin meglumine
Target species:
-
Cattle
-
Horse
-
Pig
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Flunixin meglumine82.95/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal31day
-
Milk36hour
-
-
Pig
-
Meat and offal24day
-
-
-
Intravenous use
-
Cattle
-
Meat and offal4day
-
Milk24hour
-
-
Horse
-
Meat and offal5dayΔεν επιτρέπεται η χορήγηση σε ζώα τα οποία παράγουν γάλα για ανθρώπινη κατανάλωση
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AG90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic (abridged application) - art 13(1)
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 69428/18/26-11-2019/K-0186601
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 3/11/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 3/11/2025